Eradikate Salicylic Acid Acne Treatment

Description

EradiKate Salicylic Acid Treatment is presented in a 1 oz dosage form. The product is characterized by its active ingredient, salicylic acid, which is known for its efficacy in treating acne. The treatment is packaged in a container that is suitable for topical application. The appearance of the product is consistent with its formulation, designed to deliver targeted action against blemishes. The media type associated with the product is image/jpeg, with a reference image file named "0-Image_EradiKate Salicylic Acid Treatment_1oz.jpg."

Uses and Indications

This drug is indicated for the treatment of acne. It helps keep the skin clear of new acne blemishes.

Dosage and Administration

The product should be applied 1 to 2 times weekly. Healthcare professionals are advised to instruct patients to gently apply an even layer to clean, wet skin using circular motions. The application should be left on the skin for 1 minute. Following this, the product should be gently washed off, and the skin should be patted dry.

Contraindications

The product should not be used in the following situations:

• Keep out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a poison control center immediately.

• Discontinue use and consult a physician if skin irritation occurs.

• Avoid contact with eyes. If excessive skin irritation develops or worsens, discontinue use and seek medical advice.

• Concurrent use with other topical acne medications may exacerbate skin dryness or irritation. If such reactions occur, only one medication should be utilized unless otherwise directed by a healthcare professional.

Warnings and Precautions

For external use only. It is imperative to keep this product out of reach of children. In the event that the product is swallowed, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

Users should discontinue use and consult a healthcare professional if any skin irritation occurs. Additionally, care should be taken to avoid contact with the eyes. Should excessive skin irritation develop or worsen, it is advised to stop use and seek medical advice promptly.

Side Effects

Patients should be advised that the product is for external use only. In the event of skin irritation, it is recommended to stop use and consult a doctor. This precaution is essential to ensure the safety and well-being of individuals using the product.

Drug Interactions

Concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin when used simultaneously or immediately after the application of this product. In such cases, it is advisable to limit the use to one topical medication unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient comfort and skin health.

Packaging & NDC

Below are the non-prescription pack sizes of Eradikate Salicylic Acid Acne Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event that the product is swallowed, it is crucial to seek medical assistance or contact a poison control center immediately.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus. There may be risks associated with the use of salicylic acid during this period, and it should be used only if clearly needed, with careful consideration of whether the benefits outweigh the risks. Healthcare providers should be consulted for appropriate use and dosage modifications during pregnancy to ensure the safety of both the pregnant patient and the developing fetus.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist is recommended for guidance on the appropriate management strategies tailored to the individual case.

Overall, vigilance and prompt intervention are critical in managing potential overdosage situations effectively.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

Reports of serious adverse reactions associated with the use of this product have been received through voluntary reporting and surveillance programs. Healthcare professionals and consumers are encouraged to report any serious adverse reactions to 1-800-984-KATE during weekdays from 9 A.M. to 5 P.M. PT.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a poison control center immediately.

Patients should be informed to stop using the product and consult a doctor if they experience any skin irritation. It is important to discuss the potential for increased dryness or irritation if they are using other topical acne medications simultaneously or immediately after using this product. In such cases, patients should be advised to use only one medication unless directed otherwise by a healthcare professional.

Additionally, patients should be cautioned to avoid contact with their eyes. If they experience excessive skin irritation that develops or worsens, they should discontinue use and seek medical advice.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. Currently, there are no specified storage or handling conditions provided. It is recommended that healthcare professionals refer to the product's labeling for any additional information regarding supply and storage requirements.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Eradikate Salicylic Acid Acne Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)